Antimania Drugs Market Witnesses Rapid Growth with the Emergence of Covid-19 and Resultant Surge in Neurological Diseases

Antimania Drugs Market


 Bipolar disorder, also known as manic-depressive illness, affects millions of people in the U.S. According to National Comorbidity Survey Replication past year prevalence of bipolar disorder among adults was similar for males (2.9%) and females (2.8%). An estimated 4.4% of U.S. adults experience bipolar disorder at some time in their lives. Such scenario is expected to aid in growth of the antimania drugs market.

Emergence of Covid-19 has increased the cases of neurological diseases around the world. According to a study published in September 2020, in JAMA Network Open, COVID-19 has tripled the rate of depression in US adults in all demographic groups—especially in those with financial worries. Thus, emergence of Covid-19 is also expected to aid in growth of the antimania drugs market.   

Bipolar disorder is divided into two main subtypes, namely, Bipolar I disorder (BP-I) and Bipolar II disorder (BP-II). Endoxifen is a potential new treatment option for acute mania in patients with bipolar I disorder that showed similar clinical efficacy as divalproex, without evidence of risk of thrombocytopenia. R&D of such new therapies is expected to aid in growth of the antimania drugs market.  

Bipolar disorder medications include at least one type of antidepressant. Most commonly, these medicines are in the class of monoamine oxidase inhibitors (MAOIs). These medications, which come in different varieties and are used in different ways, can effectively control the symptoms of mania and depression. However, antidepressants carry a high potential for side effects, including allergic reactions, constipation, nausea, dizziness, insomnia, suicidal thoughts, substance abuse, liver damage, and psychotic problems like hallucinations and delusions. Such side effects hinder growth of the antimania drugs market.  

Selective serotonin reuptake inhibitor (SSRI) drugs are used in the treatment of bipolar disorders. The serotonin molecule is essential in regulating mood stability, and when it is low, mood swings tend to occur. Thus, SSRI drugs can help reduce the levels of serotonin in the brain and help prevent mood fluctuations. Such advantages boost demand for SSRI drugs in the antimania drugs market. Similarly, Tamoxifen — a drug commonly used for breast cancer — has demonstrated potential as a treatment for episodes of mania in patients with bipolar disorder. Tamoxifen inhibits the intracellular action of protein kinase C, similar to other antimania drugs. 

Comments

Post a Comment

Popular posts from this blog

Astrum Has Expanded Its Presence In India Infrared Thermometer Market

Image
  The Infrared Thermometer market is witnessing the fastest growth in the Asia Pacific region and this can be accredited to the growing aging population in the region which is driving demand for healthcare services. Japan has the highest growing aging population in the country. According to the Statistics Bureau, Ministry of Internal Affairs and Communications, in 2019, the aged population (65 years old and over) was 35.89 million, constituting 28.4 percent of the total population (i.e., 1 in every 4 persons) and marking a record high in Japan. The rise in prevalence of infectious disease and increase in the demand for the product for newborns as children cannot hold the contact thermometer is playing a key role in the overall development of the infrared thermometer market . According to the World Health Organization, HIV, tuberculosis, malaria, neglected tropical diseases, and viral hepatitis affects billions of people around the world and causes more than 4 million deaths each year
Read more

The Global Meningococcal Vaccines Market Continues To Grow Owing To the Demand from Healthcare Care Sectors across the World to Prevent the Spread of the Diseases Especially In Children

Image
  Meningococcal vaccines prevent the contraction of meningococcal diseases, including meningitis caused by the bacteria called meningococcus aureus. An outbreak of meningococcal disease is usually followed by an onset of meningitis. Meningococcal meningitis can cause permanent damage to the brain or spinal cord in as little as 10 days, depending on the degree of infection and the natural immunity of the person. Since meningitis is usually associated with a fever and signs and symptoms of a serious illness, many parents prefer not to use the traditional treatments for their children such as meningitis or oral antibiotics. Instead, they often resort to various forms of therapeutic interventions that may even improve their chances of developing a positive outcome. Meningococcal vaccines are now available for meningococcal meningitis, as well as for men who have had other prior bouts of meningitis. Some vaccines used for these purposes are PPSV, Rallo, and Q fever type 1. These vaccines
Read more

Increasing Geriatric Population Is Driving the Growth of the Sexual Health Market

Image
       Sexual health is an important part of a person’s physical and mental health. According to the World Health Organization (WHO), sexual health requires a respectful and positive approach to sexual relationships and sexuality, as well as the possibility of having pleasurable and safe sexual experiences, free of coercion, violence, and discrimination. Sexual health leads to a healthy sex life without any sexually transmitted diseases, and to take preventive measures to avoid sexually transmitted infections. The elderly population (geriatric population) often suffer from one or more sexual disorders, such as premature (early) ejaculation, erectile dysfunctions, dyspareunia, and hypoactive sexual desire disorder, among others. Thus, with the increasing geriatric population worldwide, the prevalence/incidence of sexual disorders is also increasing, driving the growth of the sexual health market . According to WHO, the world's population aged 60 years and older is expected to tota
Read more